SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-023117
Filing Date
2019-11-13
Accepted
2019-11-13 13:19:14
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_bioxytraninc.htm 10-Q 348979
2 CERTIFICATION f10q0919ex31-1_bioxytran.htm EX-31.1 11141
3 CERTIFICATION f10q0919ex32-1_bioxytran.htm EX-32.1 4932
  Complete submission text file 0001213900-19-023117.txt   2959951

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bixt-20190930.xml EX-101.INS 476870
5 XBRL SCHEMA FILE bixt-20190930.xsd EX-101.SCH 38616
6 XBRL CALCULATION FILE bixt-20190930_cal.xml EX-101.CAL 30061
7 XBRL DEFINITION FILE bixt-20190930_def.xml EX-101.DEF 172269
8 XBRL LABEL FILE bixt-20190930_lab.xml EX-101.LAB 258304
9 XBRL PRESENTATION FILE bixt-20190930_pre.xml EX-101.PRE 241860
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 191212911
SIC: 2834 Pharmaceutical Preparations